AxoGen, Inc. provided revenue guidance for the full-year 2023. For the year, the company maintaining full-year 2023 revenue guidance in the range of $154 million to $159 million, which represents annual growth of 11% - 15%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.87 USD | +0.69% | -10.52% | -14.06% |
05-02 | Transcript : AxoGen, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
05-02 | Earnings Flash (AXGN) AXOGEN Posts Q1 Revenue $41.4M, vs. Street Est of $42.1M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.06% | 257M | |
+8.07% | 219B | |
+7.87% | 185B | |
+12.75% | 135B | |
-1.33% | 62.21B | |
+4.88% | 51.01B | |
+11.59% | 51.28B | |
+2.71% | 41.85B | |
+4.90% | 37.02B | |
+23.75% | 31.27B |
- Stock Market
- Equities
- AXGN Stock
- News AxoGen, Inc.
- Axogen, Inc. Provides Revenue Guidance for the Full-Year 2023